[dr_test]

Yeah, it's not 100% protection in all studies. One study did have no participants contract aids which is fantastic and would be one data point for 100% prevention.

Another had 2 participants contract HIV out of about 2000 "Person-years". This was compared to another HIV treatment where 9 people contracted HIV (with only 1k "person-years" in that cohort). This equated to 89% reduction in HIV contraction compared to the other PrEP drug.

And that IS a fantastic result and if everyone could take this we'd probably be in a great spot HIV wise. ~90% improvement over current PrEP is great, and it's way easier to take and not mess up.

[1] https://www.askgileadmedical.com/len4prep/understanding/#stu...

[kstrauser]

What’s a typical rate for infections per person-year among people not using these precautions? For those who don’t know follow the epidemiology here, how good effective are the older drugs compared to not taking them?

Having grown up when AIDS was peaking, the idea of this scourge preventable and treatable feels damn near like sci-fi, and I’m thrilled at the progress we’ve made.

[okaram]

This heavily heavily depends on the population you choose, given the difference in sexual habits.

As a data point, the paper below shows 1,213 out of 18,401 high-risk people in France got infected in 4 years (and 260 out of 31,992 with the previous gen prep, it seems this one reduces it by ~10x again)

https://www.thelancet.com/journals/lanpub/article/PIIS2468-2...

[pitpatagain]

I think it's pretty clear that being easier to take and not mess up is the reason for the difference in statistical effectiveness. The reason for lower numbers for effectiveness of daily oral Truvada prep is primarily measuring differences in adherence.

[Fomite]

We actually have terms for this.

"Efficacy" is how well something works under ideal conditions.

"Effectiveness" is how well something works in the real world.

So yes - "This is more effective because adherence is easier" is both true and intended.

[Ericson2314]

Just so where clear, from a public health as opposed to basic science standpoint, that's a distinction without a difference.

people magically get more vigilant is as leakly as virus magically goes away on its own.

[MostlyStable]

I'd be interested in a modeling study looking at the equilibrium infection rate, assuming everyone was on the drug, but otherwise did not change their behavior with regards to risky sex (or maybe even under a few scenarios of increased risky behavior from risk compensation [0]. You don't actually need 100% protection for the longterm equilibrium to be eradication of HIV (that's the whole idea of herd immunity).

How long would it take for a drug with this level of protection to result in ~no cases of HIV? What level of adoption would it require?

[0] https://en.wikipedia.org/wiki/Risk_compensation

[soared]

Be sure to model in an anti-vax effect as well

[levocardia]

A good use case for the "rule of 3":

>if a certain event did not occur in a sample with n subjects, the interval from 0 to 3/n is a 95% confidence interval for the rate of occurrences in the population.